Related Experiment Video
Updated: Dec 9, 2025

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
Published on: August 30, 2011
Acute Cardiorenal Syndrome in Heart Failure: from Dogmas to Advances
1Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, 44195, USA. tangw@ccf.org.
Insights
Acute cardiorenal syndrome (CRS) management is evolving, with new strategies focusing on effective natriuresis and addressing diuretic resistance in acute heart failure patients. Further research into novel approaches is ongoing.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Acute cardiorenal syndrome (CRS) is a significant cause of morbidity and mortality in acute heart failure.
- Understanding the pathophysiology of acute CRS, particularly renal salt and water handling, is crucial for effective management.
Purpose of the Study:
- To summarize current understanding and management strategies for acute cardiorenal syndrome (CRS).
- To highlight recent advancements and potential new treatment approaches for acute CRS.
Main Methods:
- Review of current literature on acute cardiorenal syndrome (CRS).
- Analysis of emerging strategies for managing diuretic resistance and renal dysfunction in acute heart failure.
Main Results:
- The definition of acute CRS is debated, with a focus beyond glomerular filtration impairment.
- Protocolized diuretic strategies, including loop and thiazide diuretics, acetazolamide, amiloride, or SGLT2 inhibitors, show promise for effective natriuresis.
- Novel approaches like modulating renal sodium avidity and device-based therapies warrant further investigation.
Conclusions:
- Acute CRS significantly impacts outcomes in acute heart failure.
- New insights into CRS pathophysiology may lead to improved therapeutic strategies.
- Effective management requires addressing diuretic resistance and optimizing renal function.
Purpose Of Review:
This review aims to summarize our current understanding and management strategies of acute cardiorenal syndrome (CRS).
Recent Findings:
The definition of acute CRS remains debated, in part due to the lack of reliable insights into salt and water handling of the kidneys beyond impairment in glomerular filtration. Protocolized use of loop diuretics to ensure adequate delivery to their target of action, as well as segmental tubular blockade with adjunctive use of thiazide diuretics, acetazolamide, amiloride, or sodium-glucose transporter 2 (SGLT2) inhibitors, may result in more effective natriuresis in patients with acute CRS who exhibit diuretic resistance. Other strategies, such as modulating renal sodium avidity with the use of hypertonic saline, reduction of intra-abdominal pressure, or device-based salt and volume removal, are promising and warrant further investigation. Acute CRS remains a significant contributor of morbidity and mortality for the acute heart failure population. New strategies have challenged current dogmas in our understanding of its pathophysiology, which may lead to potential new treatment approaches.
More Related Videos
07:31A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy